Shenzhen Sciencare Medical Industries Co., Ltd.
π¨π³China
- Country
- π¨π³China
- Ownership
- Private, Subsidiary
- Established
- 2017-10-24
- Employees
- 2.8K
- Market Cap
- -
- Website
- https://www.dji.com/
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)A Randomized, Double-Blind, Single-Center Clinical Study on the Efficacy of Naltrexone Implant in Antagonizing Opioid Agonist Hydromorphone
Phase 2
Completed
- Conditions
- Opioid Dependence
- Interventions
- Drug: 0.9g Naltrexone Implant + 0.6g Naltrexone Implant PlaceboDrug: 1.5g Naltrexone Implant
- First Posted Date
- 2025-06-11
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- Shenzhen Sciencare Medical Industries Co., Ltd.
- Target Recruit Count
- 31
- Registration Number
- NCT07014644
- Locations
- π¨π³
The Second Xiangya Hospital of Central South University Address: No. 139, Renmin Road Central, Changsha City, Changsha, HU Nan, China
Exploring the PK of Different Doses of Naltrexone in Patients With AUD
- First Posted Date
- 2023-06-26
- Last Posted Date
- 2023-06-26
- Lead Sponsor
- Shenzhen Sciencare Medical Industries Co., Ltd.
- Target Recruit Count
- 60
- Registration Number
- NCT05919017
- Locations
- π¨π³
Hunan Second People's Hospital, Changsha, ζΉεη, China
News
No news found